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ABSTRACT: Objective: To identify the association between non-adherence to tuberculosis treatment and 
access to treatment. Methods: A cross-sectional study was carried out in the Metropolitan Area of  Buenos 
Aires, Argentina. One hundred twenty three patients notified in 2007 (38 non adherent and 85 adherents) were 
interviewed regarding the health care process and socio-demographic characteristics. Factors associated to 
non-adherence were assessed through logistic regression analysis. Results: An increased risk of  non-adherence 
with to treatment was found in male patients (OR = 2.8; 95%CI 1.2 – 6.7), patients who had medical check-ups 
at hospitals (OR = 3.4; 95%CI 1.1 – 10.0) and those who had difficulties with transportation costs (OR = 2.5; 
95%CI 1.1 – 5.9). Conclusion: Risk of  non-adherence increases as a result of  economic barriers in accessing 
health care facilities. Decentralization of  treatment to primary health care centers and social protection 
measures for patients should be considered as priorities for disease control strategies in order to lessen the 
impact of  those barriers on adherence to treatment.
Keywords: Tuberculosis. Medication adherence. Therapeutics. Epidemiologic factors. Argentina. Decentralization
Determinants of non adherence to  
tuberculosis treatment in Argentina:  
barriers related to access to treatment
Determinantes da não adesão ao tratamento da tuberculose na Argentina:  
barreiras relacionadas com o acesso ao tratamento
María Belén HerreroI,II, Silvina RamosI, Silvina ArrossiI,II
ICentro de Estudios de Estado y Sociedad – Ciudad Autónoma de Buenos Aires, Argentina. 
IIConsejo Nacional de Investigaciones Científicas y Técnicas – Ciudad Autónoma de Buenos Aires, Argentina. 
Corresponding author: Silvina Arrossi. Sánchez de Bustamante, 27, C1173AAA, Ciudad Autónoma de Buenos Aires, Argentina.  
E-mail: silviarrossi2020@gmail.com 
Conflict of interests: nothing to declare – Financial support: Comisión Nacional Salud Investiga of the Ministry of Health of Argentina.
ORIGINAL ARTICLE / ARTIGO ORIGINAL
DOI: 10.1590/1980-5497201500020001
HERRERO, M.B., RAMOS, S., ARROSSI, S.
288
REV BRAS EPIDEMIOL APR-JUN 2015; 18(2): 287-298
INTRODUCTION
Despite the availability of  a cost-effective treatment, tuberculosis (TB) is still a major 
public health burden in developing countries1. In Argentina, TB affects around 9,500 people 
(25 cases per 100,000 people) and causes 800 deaths every year2. 
Treatment adherence is considered a key component for disease control since treatment 
disruption may result in persistent infectiousness and higher rates of  treatment failure, 
continued transmission, drug resistance, and death3. The World Health Organization (WHO) 
recommends that non-adherence should not exceed 5%4. Argentina showed a 13.8% non-
adherence rate in 20105, being one of  the highest figures in the last ten years5.
Since 1994, Direct Observed Treatment Strategy (DOTS) has been recommended for 
treatment adherence and has been introduced in TB control programs in many countries with 
varying degrees of  success6,7. Although it is widely recognized that DOTS is an important 
tool in disease control, results from different studies have shown that, both in DOTS and 
non-DOTS contexts, the patient demographic and socio-economic characteristics8-20, 
and the availability and organization of  health services are key factors influencing treatment 
adherence as well. In general, male patients, those with lower level of  education, and those 
unemployed are less likely to comply with treatment8-12. Living conditions, social support, 
transportation costs, and distance to health facilities have also shown to influence treatment 
adherence, especially in more vulnerable groups13-20. This is mainly due to factors associated 
with poverty and underdevelopment, such as poor living conditions, underlying low health 
status, lack of  money to pay for health care and inadequate access to health services21. 
RESUMO: Objetivo: Identificar a associação entre a não adesão ao tratamento da tuberculose e as características 
de acesso ao tratamento. Métodos: Um estudo transversal foi realizado na Região Metropolitana de Buenos Aires, 
Argentina. Cento e vinte e três pacientes notificados em 2007 (38 aderentes e 85 não aderentes) foram entrevistados 
sobre o processo de cuidados de saúde e características sócio-demográficas. Fatores associados a não adesão foram 
avaliados através da análise de regressão logística. Resultados: Foi encontrado um aumento do risco de não adesão 
ao tratamento em pacientes do sexo masculino (OR = 2,8, IC95% 1,2 – 6,7), pacientes que tiveram controles 
médicos em hospitais (OR = 3,4, IC95% 1,1 – 10,0) e aqueles que tiveram dificuldades com os custos de transporte 
(OR = 2.5, IC95% 1,1 – 5,9). Conclusão: O risco de não adesão aumenta como resultado de barreiras econômicas 
no acesso aos serviços de saúde. A descentralização do tratamento para os centros de atenção primária à saúde 
e medidas de proteção social para os pacientes devem ser considerados como prioridades para as estratégias de 
controle da doença, a fim de diminuir o impacto dessas barreiras na adesão ao tratamento.
Palavras-chave: Tuberculose. Adesão à medicação. Terapêutica. Fatores epidemiológicos. Argentina. Descentralização
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Financial barriers to accessing TB treatment and factors related with the attention received 
have been identified as key factors in non-compliance and treatment default10,22.
In Argentina, non-adherence rates greatly vary among provinces, from 0 to 27.3%5. 
Although the National Program for TB Control recommends DOTS as the main strategy 
for disease control, its utilization is heterogeneous due to local health systems´ capacities 
to guarantee patient supervision. From 2008 to 2010 we carried out a study to analyze how 
treatment modality (DOT versus no-DOT) and patients´ socio-demographic characteristics 
influence non-adherence to treatment23 in municipalities of  the Metropolitan Area of  Buenos 
Aires (MABA), comprising approximately 10% of  the country population. Results were 
published elsewhere23 and showed that almost all patients received non-DOT treatment 
and poverty was the predominant social explanatory factor for non-adherence. The study 
also showed that, in comparison with patients receiving treatment at hospitals, those 
treated at primary health care centers (PHCs) were more likely to adhere to treatment. 
While there is some evidence showing that better adherence at PHCs might be related to 
characteristics of  the health care process, like how health services are organized and the 
accessibility to health care services21,22, in Argentina no previous study has analyzed this 
topic. We therefore carried out an analysis of  the data, incorporating four variables to 
understand characteristics of  the health care process that influence on the capacities patients 
to comply with tuberculosis treatment23: distance to the health facility, difficulties with 
transportation costs, difficulties with transportation time, and quality of  care. The aim of  
our study was to identify the association between non-adherence to tuberculosis treatment 
and characteristics of  access to treatment. In our view, this analysis will contribute to a 
deeper understanding of  factors influencing non-adherence of  TB treatment, thus providing 
evidence to improve treatment adherence in Argentina. 
MATERIAL AND METHODS
SETTING
The study was carried out in the 6th Health Region (HRVI), located in the Southern area 
of  MABA. This is the most populated region in Buenos Aires Province, and the region where 
the majority of  TB cases are notified every year (13% of  total notified cases in Argentina, 
and 30% of  total notified in Buenos Aires Province). 
This cross-sectional study was carried out between January-December 2007. Of  the 
total 27 hospitals existing in the Region, seven hospitals from seven districts concentrate 
notification of  approximately 80% of  total notified regional cases. These are the hospitals 
that were included in the study, located in the following districts: Almirante Brown, 
Avellaneda, Berazategui, Esteban Echeverría, Ezeiza, Lomas de Zamora and Quilmes. 
During 2006-2007, the non-adherence rate for new smear-positive patients was 13.46% 
(range 5.45 – 19.16) in those districts. 
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STUDY POPULATION
Patients diagnosed with TB during 2007 who were eligible to participate in this study 
were identified through the registration records from the National Program for TB control 
(NPTB). Eligible cases were all patients with pulmonary TB, aged 18 years or older, who lived 
in any of  the selected districts, and were under drug treatment in a participating hospital 
located in the same district where the patient lived. Non-eligible cases were patients younger 
than 18 years old, those who completed treatment in a non-participating hospital, and those 
who were in prison or mentally ill during the treatment period. 
In this cross sectional study non-adherents were all eligible patients who did not adhere 
to their treatment. Following the definition used by the NPTB, a non-adherent patient was 
defined as not having received TB treatment for 60 consecutive days or more. Adherents 
were all eligible patients who completed the stipulated treatment. 
STUDY DESIGN
The study protocol was approved by the Ethics Committee of  the participating hospitals. 
Patients were called by telephone by a health team member. After obtaining a signed informed 
consent, patients were interviewed face-to-face, by an interviewer of  our team using a 
structured questionnaire. A questionnaire was developed that included socio-demographic 
and socio-economic variables as well as variables related with characteristics of  the treatment, 
of  the health care attention received and about accessibility characteristics to the heath 
care service. Counseling about the importance of  completing treatment was provided to 
non-adherent patients once the interview had finished. The questionnaire was pilot-tested 
with 10 patients (not included in the study) from the studied area. 
STATISTICAL ANALYSIS 
Stata/SE V9.0 (Stata Corp., College Station Tx, USA) was used for statistical analysis. 
The relation between health care characteristics and non-adherence to TB treatment 
(outcome) was investigated using stepwise multivariate logistic regression to control for 
potential confounding by background socio-demographic characteristics of  patients (sex, 
age, level of  education, social security, income level, occupation, head of  household social 
security). Occupation was categorized as employed with social protection (the person works 
for a public or private company and benefits from social health insurance, retirement and 
paid annual-leave), employed without social protection (the person works freelance or for 
a public or private company and does not benefit from health insurance, retirement or paid 
annual-leave), unemployed or inactive. Variables used to analyze the influence of  health 
care characteristics on treatment adherence were: type of  health facility where treatment 
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was provided (primary health centre, referral hospital), type of  health facility where control 
visits were carried out (primary health centre/others, referral hospital), difficulties in cost 
of  transportation (yes, no), difficulties with transportation time (yes, no), distance to health 
care facility (less than 3.4 kilometers, more than 3.4 kilometers). 
The significance of  the observed associations was assessed through χ2 tests; means were 
compared by independent sample t-tests. All variables with a p-value < 0.05 in univariate 
analysis were included in the multivariate logistic regression model. In the multivariate analysis, 
p-value ≤ 0.05 was considered as statistically significant. Results are presented in terms of  
risk for non-adherence (OR) with 95% confidence intervals (95%CI). In this analysis, the 
interpretation of  the OR (measuring association) was the same as relative risk (comparison 
of  risks, depending on the level of  exposure).
RESULTS
Between January-December 2007, 193 patients were eligible for this study. Seventy-eight 
(40%) did not adhere to TB treatment and 115 (60%) patients adhered. One hundred twenty 
three (64%) patients were surveyed: 38 non-adherents and 85 adherents. Forty non-adherent 
patients (51%) and 30 adherent patients (26%) could not be reached due to death, wrong 
address or relocation to another district (Table 1). 
Table 2 shows the socio-demographic characteristics of  the 123 participant patients. 
Mean age was 39 (Standard deviation – SD 1.5). 33 (27%) had never gone to school or had 
up to primary level of  education uncompleted. Ninety-eight (80%) had no health insurance, 
63 (51%) had incomes lower than 750 $ and 77 (64%) were employed without social protection. 
Eighty nine (72%) belonged to households whose heads had not social security. 
Prevalence of  characteristics related to treatment and health care organization can 
be seen in Table 3. Most patients (98%) received no-DOT treatment. Eighty three (67%) 
were treated at referral hospitals and 41 (33%) had control visits at primary health care 
centers. Ninety-three (76%) reported delays of  less than 30 minutes to receive health care 
in each visit to the health center, 62 (52%) reported difficulties in cost of  transportation 
Table 1. Treatment outcome in terms of participation in the survey. Adherent and Non-adherent 
Patients. HRVI, 2007.
Participation in the study
Non-adherents Adherents Total
n % n % n %
Yes 38 30.9 85 69.1 123 100.0
No 40 57.1 30 42.9 70 100.0
Total 78 40.4 115 59.6 193 100.0
HRVI: 6th Health Region; RS6: Região de Saúde 6.
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Table 2. Socio-demographic characteristics of patients and heads of households. Adherent and 
Non-adherent Patients. HRVI, 2007.
Characteristics 
Non-adherents Adherents Total
p-value
n = 38 % n = 85 % n = 123
Sex
Male 12 22.2 42 77.8 54
0.05
Female 26 37.7 43 62.3 69
Age (years)
18 – 24 11 37.9 18 62.1 29
ns
25 – 34 12 27.3 32 72.7 44
35 – 64 13 35.1 24 64.9 37
65 and more 2 15.4 11 84.6 13
Mean age (SD) 37 (2.3) 41 (1.8) ns
Educational level
Never gone to school/ 
Primary Incomplete
8 24.2 25 75.8 33
ns
Primary Complete 12 37.5 20 62.5 32
Secondary or more 18 31.0 40 69.0 58
Social Security
Yes 6 24.0 19 76.0 25
ns
No 32 32.7 66 67.3 98
Head of household Social Security
Yes 6 17.6 28 82.4 34
ns
No 32 36.0 57 64.0 89
Type of occupation of patients*
Employed with  
social protection
3 12.0 22 88.0 25
nsEmployed without  
social protection
27 35.1 50 64.9 77
Inactive or Unemployed 8 40.0 12 60.0 20
Household income level**
More than 750 $ 14 22.2 49 77.8 63
0.023
Up to 750 $ 24 41.4 34 58.6 58
*Missing data for one case; **Missing data for two cases; HRVI: 6th Health Region; RS6: Região de Saúde 6;  
SD: Standard deviation; ns: not significant; $: Argentine peso.
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Table 3. Prevalence of characteristics of health care received by patients. Adherent and 
Non-adherent Patients. HRVI, 2007.
Treatment and health  
care characteristics
Non-adherents Adherents Total
p-value
n = 38 % n = 85 % n = 123
DOT status
No 37 30.6 84 69.4 121
ns
Yes 1 50.0 1 50.0 2
Type of health facility were treatment was provided
Primary Health Centre 7 17.5 33 82.5 40
0.026
Referral hospital 31 37.3 52 62.7 83
Type health facility where control visits were carried out
Primary Health Centre/Others 7 17.1 34 82.9 41
0.022
Referral hospital 31 37.8 51 62.2 82
Delays in health care attention
Less than 30 minutes 30 32.3 63 67.7 93
ns
More than 30 minutes 8 26.7 22 73.3 30
Difficulties in cost of transportation*
Yes 25 40.3 37 59.7 62
0.020
No 12 20.7 46 79.3 58
Difficulties with transportation time*
Yes 13 41.9 18 58.1 31
ns
No 24 27.0 65 73.0 89
Distance to the Health Care Facility
Less than 3.4 kilometers 22 29.3 53 70.7 75
ns
More than 3.4 kilometers 16 33.3 32 66.7 48
Media distance (in kilometers)
All patients 3.4 (2.9 – 3.9)
Among cases 4 (2.6 – 5.4)
Among controls 3.1 (2.7 – 3.6)
*Missing data for three cases; DOT: Direct Observed Treatment; ; ns: not significant; HRVI: 6th Health Region;  
RS6: Região de Saúde 6.
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and 31 (25%) reported difficulties with transportation time. Most patients (61%) lived 
less than 3.4 kilometers far from the health care facility where they received treatment. 
Table 4 presents the results of  univariate and multivariate associations between health care 
characteristics and non-adherence, including socio-demographic characteristics of patients to control 
for potential confounding. Those patients who had their control visits at hospitals (OR = 3.4; 95%CI 
1.3 – 9.0) and were supplied with TB drugs at hospitals (OR = 2.8; 95%CI 1.1 – 7.1) were three 
times more likely not to adhere to treatment. It was also observed that the risk of  non-adherence 
to treatment was higher among those who had economic constrains to back transportation costs 
(OR = 2.6; 95%CI 1.1 – 5.8). Male patients (OR = 2.2; 95%CI 1.0 – 5.2) and those with the lowest 
household income (OR = 2.5, 95%CI 1.1 – 5.4) were at higher risk of  non-adherence. 
In multivariate analysis (Table 4), three variables remained significantly associated to 
non-adherence: sex, type of  health service where patients had their control visit, and having 
difficulties with transportation costs. Male patients were 2.8 times more likely to non-adhere 
to treatment (95%CI 1.2 – 6.7). Patients who had medical check-ups at hospitals had almost 
a 3.4 times higher risk of  non-adherence (95%CI 1.1 – 10.0). Patients who had difficulties 
with transportation costs had a 2.5 times higher risk of  non-adherence (95%CI 1.1 – 5.9). 
Table 4. Univariate and multivariate associations between socio-demographic, socioeconomic, 
treatment and health care characteristics and non compliance. Adherent and Non-adherent 
Patients. HRVI, 2007.
Characteristics
Univariate analysis Multivariate analysis
OR 95%CI p-value OR 95%CI p-value
Sex
Female 1
Male 2.2 (1.0 – 5.2) 0.05 2.8 (1.2 – 6.7) 0.020
Household level income
More than $750 1
Up to $750 2,5 (1.1 – 5.4) 0.025
Type of health facility were treatment was provided
Primary Health Centre 1
Referral hospital 2.8 (1.1 – 7.1) 0.029
Type health facility were control visits were carried out
Primary Health Centre/Others 1
Referral hospital 3.4 (1.3 – 9.0) 0.014 3.4 (1.1 – 10.0) 0.025
Difficulties with cost of transportation
No 1
Yes 2.6 (1.1– 5.8) 0.022 2.5 (1.1 – 5.9) 0.042
HRVI: 6th Health Region; RS6: Região de Saúde 6; OR: Odds ratio; 95%CI: 95% Confidence interval.
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DISCUSSION
To our knowledge, this is the first time that health care process characteristics are 
included in the analysis of  the social determinants of  adherence to tuberculosis treatment 
in Argentina. Our results showed that the burden of  transportation costs and the type of  
health facility are major explanatory factors. Besides, results showed that in the Argentinean 
context, being male is an important risk factor for the treatment non-adherence.
In effect, patients with difficulties regarding transportation costs presented almost three 
times higher risks of  non-adherence to treatment. Several studies have shown that costs 
related to treatment, such as transportation costs or costs associated to supplementary 
medication, negatively influences adherence18-20. They have also found that the provision 
of  drugs free of  charge is not enough to guarantee compliance, especially in lower-income 
sectors. A study in Nepal found that although the medication was provided free of  charge, 
the burden of  travel costs was a restricting factor in completing treatment19. In other study 
in Gambia, patients who spent more time travelling to the health center or had higher 
travel expenses were at higher risk of  non adherence to treatment24. Although several 
studies have found that the association between non-adherence and cost of  transportation 
is related to increasing travelling distances to receive health care9,10,18,19,25-27, in our study the 
relationship between distance to health facilities and non-adherence was not statistically 
significant, thus suggesting that for the study population, cost of  transportation is a barrier 
independently of  the distance to health care centers. 
These results confirmed our previous findings23 that showed that for a self-administered 
treatment population, patients treated at hospitals (versus those who do so in PHCs) have 
an increased risk of  non-adherence. In a study from Sudan26, authors also found a higher 
rate of  treatment success in PHCs than among patients treated at hospitals. In this context, 
decentralization to community-based tuberculosis services was highlighted as a key factor 
for treatment adherence and the lower default rate at PHCs was interpreted as an effect of  
better conditions for directly observed treatment and follow-up26. A study carried out in China 
evaluated whether decentralization results in access improvement to TB services and showed 
that patients in the decentralized group spent less on travel and treatment for TB, and that 
a higher quality of  care was observed in this group as well as better treatment outcomes28.
While several studies have analyzed how decentralization to PHC contributes to better 
outcomes by reducing distance between patient´s place and the health service19,26,28, few 
studies have focused on the health facilities’ characteristics and treatment outcomes. 
Results from a study in Peru29 aimed at evaluating users’ satisfaction with PHCs and 
hospitals showed that satisfaction was higher in PHCs. The association found in our 
study between the type of  health facility where treatment was received and patient´s 
adherence could be related to different quality of  care. However, delay in receiving 
health care (an indicator of  quality of  care) was not statistically significant with non-
adherence to treatment. Further studies are needed to indentify other health facilities’ 
characteristics that might influence non-adherence to TB treatment. 
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Our results showed that men were at higher risk of  treatment non-adherence than women. 
Studies that analyzed the relationship between sex/gender and non-adherence showed 
that men´s breadwinner status as head of  households explained their fewer adherences to 
treatment. A study conducted in India30 found that being male and being employed implied 
twice the risk of  abandoning treatment, mainly because workers have trouble in leaving 
their duties for a health care center visit. In proportion, in our study, the group of  employed 
heads of  household with social protection had higher levels of  adherence than those with 
employment but with no social protection, or those who were unemployed or inactive.
Although these differences were not significant in our study, most likely due to the small 
sample size, the fact that the majority of  patients who were heads of  households were 
male (72%) supports this hypothesis. On the same line, a study conducted in Argentina31 
on treatment adherence of  cancer patients showed that one main factor in reducing the 
adherence rate was the loss of  income resulting from disruption of  work activities during 
the treatment, especially when workers did not have any social protection. Consequently, 
household income decreases, and the capacity to afford the costs associated to treatment is 
threatened31. Another possible explanatory factor of  the lower adherence among men is that, 
in general, they have fewer contacts with the health care system. In the above mentioned study 
from India a greater adherence to treatment was found among women. They concluded that 
this might be a consequence of  women having more contacts with the health services given 
that they usually take care of  their children´s health31. In a study conducted in Nicaragua10 
authors found that male patients had a risk to drop out from treatment nearly two and a 
half  times higher than women, and that this risk was still higher after controlling for factors 
related with lifestyle behaviors, such as alcoholism, smoking and drug abuse.
This study has some limitations. Firstly, it may be affected by selection bias, as 51% of  
the non-adherent and 26% of  the adherent patients were not contacted as a consequence 
of erroneous address information. Despite this limitation, no significant statistical difference 
was found in relation to age and sex between interviewed and non-interviewed cases 
(both non-adherent and adherent patients) (Table 5). This matches with other studies 
Table 5. Socio-demographics characteristics and treatment outcome in terms of participation in 
the survey. Adherent and Non-adherent Patients. HRVI, 2007.
Socio-demographics 
Characteristics
Non-adherents (n = 78) Adherents (n = 115)
p-value
Participation in the Surrey Participation in the Surrey
Yes
n = 38
No 
n = 40
Yes
n = 85
No
n = 30
Mean age (SD) 37 (2.3) 36 (2.5) 41 (1.8) 35 (2.3) ns
Sex
Female 54,5% 45,5% 70,5% 29,5%
ns
Male 46,4% 53,6% 77,8% 22,2%
HRVI: 6th Health Region; RS6: Região de Saúde 6; SD: Standard deviation; ns: not significant.
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that have also showed a greater difficulty in reaching patients who had not comply with 
treatment18,32. Secondly, only one patient refused to take part in this study, making the 
participation rate close to 100%. Therefore it can be concluded that this study has not 
been affected by selection bias due to participation refusal.
CONCLUSION
We believe that our study contributes to the identification of  socio-economic factors 
related to non-adherence to TB treatment in Argentina. It also contributes to delineating 
the profile of  non-adherent patients: male, having difficulties with transportation costs, and 
receiving treatment at hospitals. Decentralization of  TB treatment to primary health care 
centers and social protection measures for patients in vulnerable social conditions should 
be considered priorities in TB control strategies. 
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